Arrow
Arrow
Slider

Funding

 

Current:

  1. Searching for new mechanisms of NK cells defence against selected elements of immunosuppressive tumor environment - National Science Centre, 2015/19/B/NZ6/02862 Opus, 2016-2019
  2. Identification of novel therapies potentiating the efficacy of immunotherapy with anti-CD20 antibodies in in vivo models - National Science Centre, 2015/18/E/NZ6/00702 Sonata BIS, 2016-2021
  3. Studies on the influence of selected inhibitors of kinases involved in signaling pathways in tumor cells on NK cell cytotoxicity - National Science Centre, 2014/13/N/NZ6/02081, Preludium, 2015-2017
  4. NK cells with inducible expression of CAR as a novel immunotherapy increasing the efficacy of monoclonal antibodies - National Science Centre, 2016/23/B/NZ5/02622, 2017-2019
  5. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule - National Science Centre, 2016/23/B/NZ6/02535, 2017-2019

 

Previous:

  1. Studies on the influence of drugs used in oncology on antitumor activity of anti-CD20 monoclonal antibodies - Ministry of Science and Higher Education, N N402 352938, 2010-2012
  2. Influence of hypoxia on antitumor activity of rituximab and CD20 expression in lymphoma cells - Ministry of Science and Higher Education, IP2010 046570 Iuventus Plus, 2010-2011
  3. Influence of histone deacetylases inhibitors on CD20 expression in normal and malignant B cells - Ministry of Science and Higher Education, IP2011 060271 Iuventus Plus, 2012-2014
  4. Influence of the B cell receptor (BCR) signaling pathways on CD20 levels in tumor cells and antitumor activity of anti-CD20 monoclonal antibodies – National Science Center, 2012/07/B/NZ6/03498 Opus, 2013-2016
  5. Influence of inhibition of histone deacetylases (HDACs) on the efficacy of selected antitumor therapies in the model of human tumors originating from B-cells - Ministry of Science and Higher Education, 1M19/3DG4/12 Diamond Grant, 2012-2015
  6. Identification of proteins influencing degradation of CD20 antigen - National Science Center, 2013/09/N/NZ3/01407 Preludium, 2014-2016

 

OPEN